Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Emerging Technologies & Paradigms for In Vitro Dx Europe 2024

Rebecca Whelan's Biography



Rebecca Whelan, Associate Professor of Chemistry, University of Kansas

Prof. Whelan is Associate Professor of Chemistry at the University of Kansas. She is also affiliated with the Adams Institute for Bioanalytical Chemistry and the KU Cancer Center. She earned her Ph.D. at Stanford University and did postdoctoral research at the University of Michigan. Research during her independent career has focused on applications of separations, affinity agent development, and proteomics to ovarian cancer biomarker characterization and detection.

Rebecca Whelan Image

New Insights on Ovarian Cancer Biomarker CA125

Tuesday, 19 March 2024 at 11:30

Add to Calendar ▼2024-03-19 11:30:002024-03-19 12:30:00Europe/LondonNew Insights on Ovarian Cancer Biomarker CA125Emerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Through a combination of long-read sequencing, proteomics, and mutation analysis, the Whelan lab has recently developed a new model for the ovarian cancer biomarker CA125. These results and remaining questions will be presented.


Add to Calendar ▼2024-03-18 00:00:002024-03-19 00:00:00Europe/LondonEmerging Technologies and Paradigms for In Vitro Dx Europe 2024Emerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com